MedTrace Logo

Tdap Vaccination During Pregnancy or Postpartum and Lactation-Related Outcomes

NCT07735767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36245

Last updated 2026-07-30

No results posted yet for this study

Summary

A retrospective cohort study based on the secondary use of pre-existing data. The study assesses the association between antenatal and postpartum maternal Tdap vaccination and select infant and lactation-related outcomes.

Conditions

  • Pertussis Vaccines

Interventions

BIOLOGICAL

Tetanus Toxoid, acellular pertussis, diphtheria toxoid

No investigational vaccines will be administered in this study. Participants will be included in the study on the basis of their having received Tdap vaccine as part of routine care.

Sponsors & Collaborators

Eligibility

Min Age
16 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2022-12-31
Completion
2022-12-31
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07735767 on ClinicalTrials.gov